The Indian Institute of Science has introduced an online course on machine learning for 6G wireless communication under its ...
A phase 1/2, open-label, randomized, dose-finding and dose expansion study of gedatolisib in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO ...